Front. Oral. HealthFrontiers in Oral HealthFront. Oral. Health2673-4842Frontiers Media S.A.10.3389/froh.2023.1212728Oral HealthOriginal ResearchInfluences of race/ethnicity in periodontal treatment response and bacterial distribution, a cohort pilot studyWangBing-Yan1*BurgardtGrayson1ParthasarathyKavitha12HoDaniel K.1WeltmanRobin L.13TribbleGena D.1HongJianming1CronStanley4XieHua5*School of Dentistry, University of Texas Health Science Center at Houston, Houston, TX, United StatesArthur A. Dugoni School of Dentistry, University of the Pacific, San Francisco, CA, United StatesDepartment of Clinical Sciences, University of Nevada, Las Vegas, NV, United StatesSchool of Nursing, University of Texas Health Science Center at Houston, Houston, TX, United StatesSchool of Dentistry, Meharry Medical College, Nashville, TN, United States
Edited by: Loreto Abusleme, University of Chile, Chile
Reviewed by: Sarhang Sarwat Gul, University of Sulaymaniyah, Iraq Florence Carrouel, Université Claude Bernard Lyon 1, France
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Objectives
Periodontitis disproportionately affects different racial and ethnic populations. We have previously reported the higher levels of Porphyromonas gingivalis and lower ratios of Streptococcus cristatus to P. gingivalis may contribute to periodontal health disparities. This prospective cohort study was designed to investigate if ethnic/racial groups responded differently to non-surgical periodontal treatment and if the treatment outcomes correlated to the bacterial distribution in patients with periodontitis before treatment.
Methods
This prospective cohort pilot study was carried out in an academic setting, at the School of Dentistry, University of Texas Health Science Center at Houston. Dental plaque was collected from a total of 75 African Americans, Caucasians and Hispanics periodontitis patients in a 3-year period. Quantitation of P. gingivalis and S. cristatus was carried out using qPCR. Clinical parameters including probing depths and clinical attachment levels were determined before and after nonsurgical treatment. Data were analyzed using one-way ANOVA, the Kruskal–Wallis test, the paired samples t-test and the chi-square test.
Results
The gains in clinical attachment levels after treatment significantly differed amongst the 3 groups–Caucasians responded most favorably, followed by African-Americans, lastly Hispanics, while numbers of P. gingivalis were highest in Hispanics, followed by African-Americans, and lowest in Caucasians (p = 0.015). However, no statistical differences were found in the numbers of S. cristatus amongst the 3 groups.
Conclusion
Differential response to nonsurgical periodontal treatment and distribution of P. gingivalis are present in different ethnic/racial groups with periodontitis.
periodontitisracetreatment responsePorphyromonas gingivalisStreptococcus cristatusNational Institute on Minority Health and Health Disparities, United States of Americasection-at-acceptanceOral Infections and MicrobesIntroduction
Periodontitis, recently defined as a dysbiotic disease resulting from imbalanced oral microbiota (1), is one of the most widespread inflammatory diseases in adulthood, with an estimated 42% of US dentate adults age 30 years and older suffering from some form of the disease (2). Longitudinal studies on the natural history of periodontitis suggest that modifiable and non-modifiable risk factors potentially influence the onset and progression of the disease (3–9). A series of studies has reported on periodontitis disparity amongst different racial/ethnic groups using the National Health and Nutrition Examination Survey (NHANES) I, II, and III data (7, 10, 11). In each study, African Americans (AA) had a higher incidence of periodontitis than Caucasian Americans (CA) when considering raw data. A doubling of the periodontitis incidence in AA vs. CA has been reported, even after adjusting for all co-factors (11). In a recent analysis (12), the prevalence of periodontitis was found to be highest in Hispanic Americans (HA), followed by AA, and lowest in CA.
Of the more than 700 species detected in the oral cavity only a few have been implicated to be periodontal agents (13–15). One of these putative periodontal pathogens, P. gingivalis, has been widely studied. Recently, a keystone pathogen hypothesis relating to the pathogenesis of periodontitis has been proposed, which suggests that the presence of P. gingivalis in the oral cavity, even in low-abundance, is capable of disturbing host-microbial homeostasis and thereby inducing periodontitis (16, 17). The distribution of P. gingivalis in the periodontal pockets may differ among ethnic/racial groups. Vlachojanni et al. (18) analyzed specific bacteria in subjects with periodontitis ≥40 years old and found out that antibodies against P. gingivalis MIX (mixed suspension of ATCC strains 33277 and 53978) for AA were detected 3 times more frequently than that for CA.
The pathogenicity of P. gingivalis begins with its bacterial adherence in the oral cavity (19). P. gingivalis uses multiple cellular and extracellular components such as fimbriae, proteases, and hemagglutinins for adherence (20, 21). FimA, a major subunit of long fimbriae of P. gingivalis, is a well-studied virulence factor contributing to colonization, biofilm formation, cell invasion, bone resorption, and the evasion of host defense systems (22–29). FimA is capable of modifying the host response by activating cytokines such as IL-1, IL-6, IL-8, and TNF-α (21, 30) and also mediates coaggregation of P. gingivalis with microbes such as Actinomyces viscous, Streptococcus gordonii, and Streptococcus oralis (21, 31). Previously, we demonstrated that the expression of P. gingivalis fimA was repressed in the presence of arginine deiminase of Streptococcus cristatus, which led to inhibition of the formation of P. gingivalis biofilms (32–35). The inhibition of biofilm formation by S. cristatus arginine deiminase is species-specific and influences P. gingivalis only. We also found a negative correlation of distributions of S. cristatus and P. gingivalis in dental plaques of periodontitis patients and that S. cristatus interfered with alveolar bone loss induced by P. gingivalis in the murine oral cavity (33, 36).
We have recently demonstrated that increase in levels of P. gingivalis and lower ratios of S. cristatus to P. gingivalis are potential risk factors of disparities in periodontal health and periodontitis severity (37, 38). In this study, we investigated if ethnic/racial groups responded differently to non-surgical periodontal treatment and if the treatment outcomes correlated to the bacterial distribution before treatment. The initial non-surgical treatment for periodontitis is scaling and root planning (SRP). Although SRP has been universally used in the treatment of periodontitis, to our knowledge, it has not been demonstrated if racial/ethnic background influences the response to this treatment. Therefore, this study was designed to test the null hypothesis that racial/ethnic background does not influence the clinical response to SRP and/or the distribution of P. gingivalis and S. cristatus in periodontitis sites in the oral cavity.
Materials and methodsStudy design
The study was carried out in an academic setting, at the School of Dentistry, University of Texas Health Science Center at Houston. After screening to determine eligibility and obtaining informed consent, subjects were recruited into the study. All subjects underwent a full-mouth examination for periodontal status, during which microbial samples were collected. Periodontal parameters (probing depth and clinical attachment loss) were abstracted from the Electronic Health Record at our institute, prior to and 6 weeks post nonsurgical periodontal treatment. Participant enrollments and dental plaque sample collections were carried out within a 3-year period. Clinical parameters extraction and statistical analysis were completed after all participants came to their 6-week re-evaluation. Those failed the 6-week follow-up were excluded from our study.
If simple size is calculated based on power analysis using G*power 3.1, by choosing a statistic power = 0.85, α = 0.05, and an effect size of 0.2 (small to moderate by Cohen) (39), a total sample size of 279 would be required. However, our study is a pilot study. The study was terminated at 75 participants, when significant differences in treatment response and bacterial distribution amongst 3 racial groups were found.
Patient enrollment
The research protocol was approved by the Committee for the Protection of Human Subjects of University of Texas Health Science Center at Houston (IRB number: HSC-DB-11-0634). Candidates were screened during their routine dental visits to determine if they meet the inclusion criteria: having been diagnosed as generalized periodontitis Stage II or III, regardless of their grading (40, 41); age of 21–65; and with self-reported ethnicity/race of non-Hispanic Caucasian Americans (CA), non-Hispanic African Americans (AA), or Hispanic Americans (HA). They were excluded from the study if they had antibiotics within 6 months; periodontal therapy within one year; current smokers; pregnant or systemic conditions such as diabetes that are known to influence the outcome of periodontitis treatment. They were enrolled when they met the criteria and signed the written consent for participation. The signed consent forms were stored in a locked drawer in PI's office at the School of Dentistry, UTHealth at Houston. In addition, the participants who failed the 6-week follow-up were excluded from our study.
Plaque sample collection
Dental plaque samples were collected from mesial or distal sites on two posterior teeth with 5–7 mm probing depth in different quadrants, using paper points before any treatment. The samples contain primarily subgingival dental plaque. The paper points were inserted into the pockets for 1 min and were immersed immediately in 0.5 ml of Tris-EDTA (TE) buffer (pH 7.5). Bacteria were harvested by centrifugation at 16,873×g for 3 min. The pellet was resuspended in 50 µl TE buffer. Chromosomal DNA was released by 2 cycles of freezing (at −80°C overnight) and boiling for 20 min.
Bacterial quantitation by qPCR
P. gingivalis cells and S. cristatus cells were enumerated by qPCR, using a Bio-Rad CFX 96 real-time PCR system (Bio-Red Laboratories Inc., Redmond, WA, USA). qPCR was performed in duplicate using 5 µl sample DNA, 10 µl SYBR Green PCR mix (Bio-Red Laboratories Inc., Redmond, WA, USA), and 0.4 µM of each forward and reverse primers [TGTAGATGACTGATGGTGAAA and ACTGTTAGCAACTACCGATGT for P. gingivalis species-specific 16S rDNA gene (42) or CTGACGAAGCGAAAGGTCTG and ATGTGGTTGAGCGATACAGC for S. cristatus arcA gene], in a total volume of 20 µl. After initial incubation of 95°C for 3 min, denaturation (95°C for 3 s) followed by primer annealing and extension (60°C for 30 s) was performed for 40 cycles, according to manufacturer's recommendation. Standards used to quantitate P. gingivalis or S. cristatus in the plaque samples were prepared using genomic DNAs from P. gingivalis 33277 or S. cristatus CC5A (33). The qPCR was performed by individual who was blinded with participant's demographics.
Non-surgical periodontal treatment
All patients underwent SRP, the standard of care when initiating treatment of periodontitis. SRP was carried out using ultrasonic and hand instruments, under local anesthesia. Five to ten minutes were spent for each tooth, depending on disease severity. SRP was completed in 2 visits. Oral hygiene instruction (brushing and flossing) was given prior to initiating SRP and reinforced at each clinic visit. No other supplementary treatment was provided.
Determination of clinical parameter
A complete periodontal examination for each patient was carried out before treatment and again 6 weeks after completion of the non-surgical periodontal therapy by the assigned dental student and verified by the supervising clinician. The clinicians participating in the study are board-certified periodontists who had been calibration in measurement of probing depths (PD) and clinical attachment level (CAL) before the initiation of the study.
Two of the parameters, PD and CAL were used for analyzing clinical treatment responses in this study and were abstracted from the Electronic Health Record at our institute. In addition to the clinical treatment outcome measurements at the bacterial sampling sites, the treatment responses of all of the SRP sites (those with ≥5 mm initial PDs) and the full mouth (all teeth excluding wisdom teeth) were analyzed.
Statistical analysis
One-way analysis of means (ANOVA) for continuous variables and the chi-square test for categorical variables were performed to determine the difference in response to SRP and in bacterial distribution, and patients' demographics. Continuous variables were assessed for normality. Kruskal–Wallis, a non-parametric test, was performed when data was not normally distributed. The comparison of the baseline means vs. the means at the 6-week re-evaluation within each ethnic/racial group was analyzed using the paired samples t-test. Linear regression was used to measure the association between the levels of P. gingivalis with the treatment responses. A difference was considered significant when a p-value <0.05 was obtained.
ResultsPatient population
Seventy-five subjects diagnosed with generalized periodontitis (based on generalized radiographic alveolar bone loss, >30% sites with CAL >2 mm, and ≥5 mm PD at multiple teeth in ≥2 quadrants) and completed their 6-week follow-up visits were enrolled in the study. Of the total of 75 subjects entered into the study, 17 were AAs, 20 were CAs, and 38 were HAs. The average age of the subjects was 49.4 years, and 49.3 percent of the subjects were women. The subjects had an average of 26.5 teeth. There were no statistical differences in age, gender, or existing numbers of teeth before treatment amongst 3 racial/ethnic groups (Table 1).
Population demography.
Subject enrolled
Gender (F/Ma)
Age
Number of teeth
CA
20
8/12
51.9 ± 10.0
26.75 ± 1.97
AA
17
10/7
50.2 ± 10.7
25.65 ± 4.17
HA
38
19/19
47.8 ± 12.3
26.71 ± 2.85
ALL
75
37/38
49.4 ± 11.4
26.48 ± 3.00
CA, Caucasian Americans; AA, African Americans; HA, Hispanic Americans; ALL, all subject enrolled.
Female/male.
Response to SRP
The clinical responses to SRP were analyzed by comparison of CAL and PD before treatment and at 6-week re-evaluation. One-way ANOVA was performed to determine the differences in treatment responses amongst the three ethnic/racial groups, using data from the bacterial sampling sites, the SRP sites, and the full-mouth (the whole dentition excluding wisdom teeth). There were no statistical differences in CALs or PDs at baseline amongst 3 racial/ethnic groups (the Before Treatment columns in Tables 2–4). Analysis of the CAL gains in response to SRP at the two sampling sites revealed a statistically significant difference amongst the 3 groups (p = 0.041). Post hoc comparisons with the Tukey test indicated that the CAL gains in CAs was statistically different from HAs (p = 0.031), but not from AAs (p = 0.258). No statistical difference was found between AA and HA groups (p = 0.792). No statistical differences in PDs and PD reductions were found between any of the ethnic/racial groups (p > 0.05, Table 2).
Sampling-site clinical parameters in response to SRP.
Before treatment
Re-evaluation
ΔChange
CAL
PD
CAL
PD
CAL
PD
CA
5.28 ± 1.83
6.05 ± 1.38
3.58 ± 1.78
4.28 ± 0.96
1.69 ± 1.30
1.83 ± 1.07
AA
4.94 ± 1.52
6.15 ± 0.79
4.00 ± 1.46
4.91 ± 0.92
0.97 ± 0.88
1.19 ± 1.06
HA
4.64 ± 1.67
5.84 ± 1.31
3.93 ± 1.48
4.55 ± 1.41
0.71 ± 1.49
1.26 ± 1.12
ALL
4.88 ± 1.68
5.97 ± 1.22
3.86 ± 1.54
4.56 ± 1.21
1.01 ± 1.37
1.39 ± 1.11
p-value
0.398
0.656
0.676
0.325
0.041a
0.139
CAL and PD at the bacterial sampling sites are presented as mean ± SD in mm. CA, Caucasian Americans; AA, African Americans; HA, Hispanic Americans; ALL, all subject enrolled.
The mean difference of ΔChange in sampling-site CAL is significant at the <0.05 level amongst 3 ethnic/racial groups (One-way ANOVA).
SRP-site clinical parameters in response to SRP.
Before treatment
Re-evaluation
ΔChange
CAL
PD
CAL
PD
CAL
PD
CA
4.66 ± 1.28
5.00 ± 0.57
3.84 ± 0.92
3.81 ± 0.66
0.77 ± 1.33
1.19 ± 0.64
AA
4.22 ± 0.92
4.87 ± 0.32
4.46 ± 0.89
3.86 ± 0.51
−0.25 ± 1.35
1.01 ± 0.59
HA
4.39 ± 1.30
4.91 ± 0.49
4.12 ± 0.88
3.75 ± 0.59
0.28 ± 1.33
1.16 ± 0.68
ALL
4.43 ± 1.21
4.93 ± 0.48
4.11 ± 0.91
3.79 ± 0.59
0.30 ± 1.36
1.13 ± 0.64
p-Value
0.523
0.666
0.123
0.804
0.077
0.657
CAL and PD at the SRP sites are presented as Mean ± SD in mm. CA, Caucasian Americans; AA, African Americans; HA, Hispanic Americans; ALL, all subject enrolled.
Full-mouth clinical parameters in response to SRP.
Before treatment
Re-evaluation
ΔChange
CAL
PD
CAL
PD
CAL
PD
CA
2.53 ± 0.88
3.08 ± 0.52
2.19 ± 1.01
2.71 ± 0.42
0.37 ± 0.56
0.39 ± 0.35
AA
2.41 ± 0.85
3.34 ± 0.46
2.07 ± 0.83
2.87 ± 0.26
0.35 ± 0.39
0.42 ± 0.32
HA
2.56 ± 0.99
3.19 ± 0.53
2.23 ± 0.37
2.84 ± 0.93
0.27 ± 0.49
0.32 ± 0.29
ALL
2.51 ± 0.92
3.19 ± 0.51
2.18 ± 0.94
2.81 ± 0.36
0.32 ± 0.49
0.36 ± 0.31
p-Value
0.872
0.292
0.850
0.348
0.770
0.504
CAL and PD of all sites in the full dentition are presented as Mean ± SD in mm. CA, Caucasian Americans; AA, African Americans; HA, Hispanic Americans; ALL, all subject enrolled.
Analysis of data from the SRP sites revealed similar results as at the bacterial sampling sites. For the CAL gains of all the SRP sites, CA responded most favorably relative to AA and HA, in accordance with the results of the bacterial sampling sites, although the p value of one-way ANOVA analysis did not reach significance (p = 0.077). There were no statistical differences in the mean PDs and PD reductions amongst three ethnic/racial groups (Table 3).
There was no statistically significant mean difference in any full-mouth clinical parameter amongst 3 ethnic/racial groups (Table 4). Since more than half of the PD sites were ≤3 mm, we analyzed the percentages of full-mouth CAL and PD (in mm) amongst ethic/racial groups before and after SRP. CAL and PD at baseline and re-evaluation were stratified into CAL ≤2 mm, =3–4 mm, ≥5 mm and PD ≤3 mm, =4–5 mm, ≥6 mm. Full-mouth data thus stratified demonstrated an increase in the percentage of sites with PDs of ≤3 mm (from 69.9% to 83.8%) and a decrease in the percentage of sites with PDs of ≥4 mm (from 30.1% to 16.2%) as a result of SRP (Figure 1). Full-mouth data also demonstrate that the percentage of sites with CALs of ≤2 mm increased (from 53.7% to 59.6%) and the percentage of sites with CALs of ≥3 mm decreased (from 46.3% to 39.4%) as a result of SRP. No statistically significant differences were found in PDs, PD reductions, CALs, and CAL gains amongst the three ethnic/racial groups in the full-mouth analysis (Figure 1).
Percentages of full-mouth CALs and PDs (in mm) amongst ethnic/racial groups before and after SRP. CALs and PDs before treatment and at reevaluation were stratified into CAL ≤2 mm, =3–4 mm, ≥5 mm and PD ≤3 mm, =4–5 mm, ≥6 mm. The mean ± SD of percentages of the stratified clinical parameters (CAL on the upper panel, PD on the lower panel) before (Initial) and after (Re-eval) SRP are shown. There was no significant difference amongst 3 ethnic/racial groups (One-way ANOVA).
Comparison of the means at the baseline vs. the means at the 6-week re-evaluation within each ethnic/racial group was analyzed using the paired samples t-test. There was statistically significant reduction in both PD and CAL at the sample sites, SRP sites and the whole dentition for all the groups (p < 0.01).
Distributions of <italic>P. gingivalis</italic> and <italic>S. cristatus</italic>
Dental plaque samples from the two 5–7 mm PD sites per subject before treatment were used for qPCR to quantitate P. gingivalis and S. cristatus. As shown in Table 5, HAs exhibited the greatest numbers of P. gingivalis and S. cristatus, and AAs had more P. gingivalis and less S. cristatus than CAs. The high skewness values, ranging from 5.249 for S. cristatus counts to 5.975 for P. gingivalis counts, prevented meaningful comparisons of the mean differences amongst the 3 different ethnic/racial groups. Therefore, Statistically significant disparity in P. gingivalis distribution was observed among the three ethnic/racial groups using the Kruskal–Wallis, a nonparametric test (p = 0.015). Significant disparity was not found in S. cristatus distribution (p = 0.630).
Distribution of P. gingivalis and S. cristatus in cell counts.
P. gingivalis
S. cristatus
CA
3,204 ± 9,914
43,438 ± 117,931
AA
16,615 ± 24,251
18,230 ± 24,564
HA
2,299,608 ± 9,407,308
70,504 ± 2,007,328
p-Value
0.015a
0.063
Bacterial cell counts were determined by qPCR and presented as Mean ± SD.
The mean difference of P. gingivalis is significant at the 0.05 level amongst 3 ethnic/racial groups (Kruskal–Wallis test).
The correlation of the P. gingivalis levels with treatment responses was analyzed using linear regression analysis. Although there were significant differences in the levels of P. gingivalis and the changes in CAL after SRP amongst 3 races (Tables 2, 5), association of P. gingivalis numbers with either PD or CAL was not detected (p = 0.135 and 0.081, respectively). This could be due to the large variation in the levels of P. gingivalis and relatively small sample size.
Discussion
Race has been shown to be one of many risk factors for periodontitis (7, 9, 12, 18). We have previously demonstrated that levels of P. gingivalis, a keystone periodontal pathogen, was not evenly distributed among the three racial/ethnic groups, and the ratio of S. cristatus to P. gingivalis to be significantly higher in CAs than in HAs and AAs (37, 38), which suggest that higher levels of P. gingivalis and lower ratios of S. cristatus to P. gingivalis may contribute to periodontal health disparities.
This study sought to determine if ethnicity/race influences periodontal treatment response and bacterial distribution in dental plaque in periodontitis patients. Disparity in treatment response to SRP and in the distribution of P. gingivalis was found among the three ethical/racial groups studied. Therefore, the null hypothesis–racial/ethnic background does not influence response to nonsurgical periodontal therapy and/or the distribution of P. gingivalis and S. cristatus in periodontal patients, is rejected.
The diagnosis of generalized periodontitis Stage II or III in our inclusion criteria is based on the new classification of periodontitis in the 2017 World Workshop on the Classification of Periodontal and Peri-implant Diseases and Conditions (40, 41). Patients is eligible if they exhibited interdental CAL of 3 mm and above, alveolar bone loss of 15% and beyond, tooth loss due to periodontitis ≤4 teeth. The age limit of 21–65 is to minimize the influence of aging on periodontium. We excluded the antibiotics usage, previous periodontal therapy, current smoker, pregnancy and diabetes, since the usage of antibiotics, periodontal therapy and pregnant will influence the dental biofilm components and/or amount; and current smokers, and diabetes are known to influence the outcome of periodontitis treatment.
Our results indicate that ethnic/racial backgrounds and higher P. gingivalis counts may adversely influence the outcome of periodontal treatment. The ethnic/racial backgrounds in this study were based on self-reporting by the subjects after they were diagnosed with generalized periodontitis. Because of the study location (Houston, Texas, USA), majority of the HAs enrolled were Mexican-Americans.
To evaluate response to SRP, we statistically analyzed changes in PDs and CALs, the two most commonly utilized clinical outcome measures. CALs were calculated as PD—(FGM-CEJ) with a negative number of FGM-CEJ (free gingival margin to the cementoenamel junction) indicating gingival recession. In this calculation format, the values of the CALs at reevaluation were less than those before treatment (Tables 2–4). Our calculation format may differ from other institutions and dental offices. The term “gains in CAL” in this article indicated the improvements of CALs in response to SRP, in accordance with other publications (43–46).
The responses to SRP inversely correlate to initial probing depths. Sites with deeper initial probing depths have been found to achieve greater improvements in probing depth reduction and attachment gain after SRP (47). In our study, the dental plaques were sampled from the two 5–7 mm periodontal pockets with an average PD of 5.97 mm before treatment. Since the full-mouth data contained a large percentage of shallow PDs, full-mouth response to treatment was skewed such that the most severely associated sites were masked by the preponderance of shallower sites (Figure 1). Clinical outcome measures for the most severely affected sites were presented separately from the mean whole mouth data to show the response to SRP at those sites exhibiting periodontitis and thus with deep initial probing depths (PDs ≥5 mm). Both the bacterial sampling sites and the SRP-sites (the sites on teeth with PDs measuring ≥5 mm) showed similar treatment outcome, i.e., that CAs responded more favorably to non-surgical periodontal therapy, relative to AAs and HAs (Tables 2, 3).
Total bacterial amounts differed tremendously among the participants of this study with the counts of a specific bacterium varying in a large range as shown in our study (Table 5). This caused an asymmetry of the probability distribution, which was measured by skewness in statistical analysis. Thus, the Kruskal–Wallis test, a nonparametric test, was used instead of ANOVA to analyze bacterial distribution amongst three ethnic/racial groups. Our results indicate that caution should be taken for bacterial count analysis from clinical samples. The standard deviations exceeded the mean counts for each bacterium for every ethnicity/race in our study, indicating a very large range in counts. This skewed distribution in bacterial counts causes shifting of the means towards the few extremely large values, as shown in Table 5 for HAs. Therefore, determination of skewness should be carried out for any parameter, prior to clinical data analysis.
We also analyzed the ratio of P. gingivalis or S. cristatus to the whole bacterial amount in the plaque, in an attempt to normalize the bacterial distribution. The whole bacterial amount was determined via qPCR using universal primers (Cyanobacterial 16S rRNA: GGGCTACACACGYGCWAC, GACGGGCGGTGTGTRCA) (48). However, the percentages of the two bacteria in the total amount exhibited even larger skewness than their original numbers (date not shown), which prohibited us to normalize data in this way.
The treatment responses were analyzed at 6 weeks after SRP in our study. We realize this is much shorter than commonly reported results of 3 months and longer (49–52). However, 6-week re-evaluation is necessary for decision making for further periodontal treatment if deep PDs persist after SRP (53, 54). The current guideline for treating periodontal patient at our School is to re-evaluate 4–6 weeks after SRP. If the deep PDs (≥6 mm) persist, refer the patient for periodontal surgery. Therefore, we chose 6 weeks after SRP as our re-evaluation point. The treatment responses at 6 weeks after SRP in our study were comparable to the 2 reports with the same re-evaluation time points. Statistically significant differences in reduction of CAL and/or PD are detected at 6 weeks after SRP (55, 56). The strength of this study is our emphasis on the racial disparity in treatment response 6 weeks after SRP and in distributions of P. gingivalis (a keystone pathogen in periodontitis) and S. cristatus (its arginine deiminase inhibits P. gingivalis biofilm formation).
This study is carried out in an academic setting. Therefore, the participants may not present the populations in the community. Additionally, the treatment response was evaluated on 75 periodontal patients, only in 6 weeks after SRP. In addition, other periodontal parameters such as bleeding on probing and plaque index are not included. Studies with more participants, longer evaluation period and more clinical parameters will have to be carried out in future to further confirm our findings.
In conclusion, within the limits of this pilot study, disparities exist in clinical response to non-surgical periodontal therapy and in P. gingivalis counts amongst ethnic/racial groups with periodontitis, which may merit more frequent periodontal maintenance visits for HAs and AAs after SRP. In addition, caution should be taken for bacterial count analysis from clinical samples, due to the asymmetry of the probability distribution.
Data availability statement
The datasets presented in this article are not readily available because: the original contributions presented in the study are included in the article material. Further inquiries can be directed to the corresponding authors.
Ethics statement
The studies involving human participants were reviewed and approved by the Committee for the Protection of Human Subjects of the University of Texas Health Science Center at Houston. The patients/participants provided their written informed consent to participate in this study. The patients/participants provided their written informed consent to participate in this study.
Author contributions
HX and BW conceived the study and supervised the project. GB, BW, KP, DH, RW enrolled study participants. JH, with the supervision of GT and BW, carried out sample process and qPCR. SC performed the statistical analyses. All authors contributed to the article and approved the submitted version.
Funding
The study was supported in part by grant MD007586 from the National Institute on Minority Health and Health Disparities, United States of America.
Acknowledgments
The authors are grateful to all enrolled subjects for their participation in this research. The authors thank Krishna Kookal for abstracting clinical parameters from the Electronic Health Records at the School of Dentistry.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
ReferencesHajishengallisGLamontRJ. Polymicrobial communities in periodontal disease: their quasi-organismal nature and dialogue with the host. Periodontol 2000. (2021) 86:210–30. 10.1111/prd.1237133690950EkePIThornton-EvansGOWeiLBorgnakkeWSDyeBAGencoRJ. Periodontitis in US adults: national health and nutrition examination survey 2009–2014. J Am Dent Assoc. (2018) 149:576–88.e6. 10.1016/j.adaj.2018.04.02329957185GencoRJBorgnakkeWS. Risk factors for periodontal disease. Periodontol 2000. (2013) 62:59–94. 10.1111/j.1600-0757.2012.00457.x23574464GrossiSGZambonJJHoAWKochGDunfordRGMachteiEEAssessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol. (1994) 65:260–7. 10.1902/jop.1994.65.3.2608164120MichalowiczBSAeppliDViragJGKlumpDGHinrichsJESegalNLPeriodontal findings in adult twins. J Periodontol. (1991) 62:293–9. 10.1902/jop.1991.62.5.2932072240KornmanKSCraneAWangHYdi GiovineFSNewmanMGPirkFWThe interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. (1997) 24:72–7. 10.1111/j.1600-051X.1997.tb01187.x9049801BorrellLNBurtBANeighborsHWTaylorGW. Social factors and periodontitis in an older population. Am J Public Health. (2004) 94:748–54. 10.2105/AJPH.94.5.74815117695BorrellLNTalihM. Examining periodontal disease disparities among U.S. adults 20 years of age and older: NHANES III (1988–1994) and NHANES 1999–2004. Public Health Rep. (2012) 127:497–506. 10.1177/00333549121270050522942467Thornton-EvansGEkePWeiLPalmerAMoetiRHutchinsSPeriodontitis among adults aged >/=30 years—United States, 2009–2010. Morb Mortal Wkly Rep Surveill Summ. (2013) 62(Suppl 3):129–35. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/su6203a21.htmBorrellLNBurtBAGillespieBWLynchJNeighborsH. Periodontitis in the United States: beyond black and white. J Public Health Dent. (2002) 62:92–101. 10.1111/j.1752-7325.2002.tb03428.x11989212BorrellLNBurtBAWarrenRCNeighborsHW. The role of individual and neighborhood social factors on periodontitis: the third national health and nutrition examination survey. J Periodontol. (2006) 77:444–53. 10.1902/jop.2006.05015816512759EkePIDyeBAWeiLSladeGDThornton-EvansGOBorgnakkeWSUpdate on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. (2015) 86:611–22. 10.1902/jop.2015.14052025688694SocranskySSHaffajeeADCuginiMASmithCKentRLJr. Microbial complexes in subgingival plaque. J Clin Periodontol. (1998) 25:134–44. 10.1111/j.1600-051X.1998.tb02419.x9495612JenkinsonHFLamontRJ. Oral microbial communities in sickness and in health. Trends Microbiol. (2005) 13:589–95. 10.1016/j.tim.2005.09.00616214341DewhirstFE. The oral microbiome: critical for understanding oral health and disease. J Calif Dent Assoc. (2016) 44:409–10. 10.1080/19424396.2016.1222103327514152HajishengallisGLiangSPayneMAHashimAJotwaniREskanMALow-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. (2011) 10:497–506. 10.1016/j.chom.2011.10.00622036469HajishengallisGDarveauRPCurtisMA. The keystone-pathogen hypothesis. Nat Rev Microbiol. (2012) 10:717–25. 10.1038/nrmicro287322941505VlachojannisCDyeBAHerrera-AbreuMPikdokenLLerche-SehmJPretzlBDeterminants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol. (2010) 37:685–96. 10.1111/j.1600-051X.2010.01592.x20561113AmanoA. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J Periodontol. (2003) 74:90–6. 10.1902/jop.2003.74.1.9012593602HoltSCKesavaluLWalkerSGencoCA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. (1999) 20:168–238. 10.1111/j.1600-0757.1999.tb00162.x10522227HamadaSAmanoAKimuraSNakagawaIKawabataSMorisakiI. The importance of fimbriae in the virulence and ecology of some oral bacteria. Oral Microbiol Immunol. (1998) 13:129–38. 10.1111/j.1399-302X.1998.tb00724.x10093527BeltonCMIzutsuKTGoodwinPCParkYLamontRJ. Fluorescence image analysis of the association between Porphyromonas gingivalis and gingival epithelial cells. Cell Microbiol. (1999) 1:215–23. 10.1046/j.1462-5822.1999.00022.x11207554WeinbergABeltonCMParkYLamontRJ. Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun. (1997) 65:313–6. 10.1128/iai.65.1.313-316.19978975930LamontRJChanABeltonCMIzutsuKTVaselDWeinbergA. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun. (1995) 63:3878–85. 10.1128/iai.63.10.3878-3885.19957558295SandrosJPapapanouPNNannmarkUDahlenG. Porphyromonas gingivalis invades human pocket epithelium in vitro. J Periodontal Res. (1994) 29:62–9. 10.1111/j.1600-0765.1994.tb01092.x8113953DornBRDunnWAJrProgulske-FoxA. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun. (1999) 67:5792–8. 10.1128/IAI.67.11.5792-5798.199910531230DornBRBurksJNSeifertKNProgulske-FoxA. Invasion of endothelial and epithelial cells by strains of Porphyromonas gingivalis. FEMS Microbiol Lett. (2000) 187:139–44. 10.1111/j.1574-6968.2000.tb09150.x10856647DeshpandeRGKhanMBGencoCA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun. (1998) 66:5337–43. 10.1128/IAI.66.11.5337-5343.19989784541NjorogeTGencoRJSojarHTHamadaNGencoCA. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun. (1997) 65:1980–4. 10.1128/iai.65.5.1980-1984.19979125593LamontRJJenkinsonHF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol. (2000) 15:341–9. 10.1034/j.1399-302x.2000.150601.x11154429YoshimuraFMurakamiYNishikawaKHasegawaYKawaminamiS. Surface components of Porphyromonas gingivalis. J Periodontal Res. (2009) 44:1–12. 10.1111/j.1600-0765.2008.01135.x18973529XieHLinXWangBYWuJLamontRJ. Identification of a signalling molecule involved in bacterial intergeneric communication. Microbiology. (2007) 153:3228–34. 10.1099/mic.0.2007/009050-017906122WangBYWuJLamontRJLinXXieH. Negative correlation of distributions of Streptococcus cristatus and Porphyromonas gingivalis in subgingival plaque. J Clin Microbiol. (2009) 47:3902–6. 10.1128/JCM.00072-0919846640XieHChungWOParkYLamontRJ. Regulation of the Porphyromonas gingivalis fimA (fimbrillin) gene. Infect Immun. (2000) 68:6574–9. 10.1128/IAI.68.12.6574-6579.200011083767WuJXieH. Role of arginine deiminase of Streptococcus cristatus in Porphyromonas gingivalis colonization. Antimicrob Agents Chemother. (2010) 54:4694–8. 10.1128/AAC.00284-1020660674XieHHongJSharmaAWangBY. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice. J Periodontal Res. (2012) 47:578–83. 10.1111/j.1600-0765.2012.01469.x22448761WangBYLuTCaiQHoMHShengSMengHWPotential microbiological risk factors associated with periodontitis and periodontal health disparities. Front Cell Infect Microbiol. (2021) 11:789919. 10.3389/fcimb.2021.78991934869082WangBYCaoAHoMHWilusDShengSMengHWIdentification of microbiological factors associated with periodontal health disparities. Front Cell Infect Microbiol. (2023) 13:1137067. 10.3389/fcimb.2023.113706736875522CohenJ. A power primer. Psychol Bull. (1992) 112:155–9. 10.1037/0033-2909.112.1.15519565683PapapanouPNSanzMBuduneliNDietrichTFeresMFineDHPeriodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. (2018) 89(Suppl 1):S173–82. 10.1002/JPER.17-072129926951TonettiMSGreenwellHKornmanKS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. (2018) 89(Suppl 1):S159–72. 10.1002/JPER.18-000629926952TranSDRudneyJD. Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol. (1999) 37:3504–8. 10.1128/JCM.37.11.3504-3508.199910523542HaffajeeADCuginiMADibartSSmithCKentRLJrSocranskySS. The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol. (1997) 24:324–34. 10.1111/j.1600-051X.1997.tb00765.x9178112GoodsonJMHoganPEDunhamSL. Clinical responses following periodontal treatment by local drug delivery. J Periodontol. (1985) 56(Suppl 11S):81–7. 10.1902/jop.1985.56.11s.81BaderstenANilveusREgelbergJ. Effect of nonsurgical periodontal therapy (VIII). Probing attachment changes related to clinical characteristics. J Clin Periodontol. (1987) 14:425–32. 10.1111/j.1600-051X.1987.tb01548.x3476520MombelliAMuhleTFriggR. Depth-force patterns of periodontal probing. Attachment-gain in relation to probing force. J Clin Periodontol. (1992) 19:295–300. 10.1111/j.1600-051X.1992.tb00647.x1517472MorrisonECRamfjordSPHillRW. Short-term effects of initial, nonsurgical periodontal treatment (hygienic phase). J Clin Periodontol. (1980) 7:199–211. 10.1111/j.1600-051X.1980.tb01963.x7000853TurnerSPryerKMMiaoVPPalmerJD. Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J Eukaryot Microbiol. (1999) 46:327–38. 10.1111/j.1550-7408.1999.tb04612.x10461381ClaffeyNLoosBGantesBMartinMEgelbergJ. Probing depth at re-evaluation following initial periodontal therapy to indicate the initial response to treatment. J Clin Periodontol. (1989) 16:229–33. 10.1111/j.1600-051X.1989.tb01646.x2654197AljateeliMKotichaTBashutskiJSugaiJVBraunTMGiannobileWVSurgical periodontal therapy with and without initial scaling and root planing in the management of chronic periodontitis: a randomized clinical trial. J Clin Periodontol. (2014) 41:693–700. 10.1111/jcpe.1225924730621MagnussonIClarkWBLowSBMaruniakJMarksRGWalkerCB. Effect of non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with “refractory” periodontal disease. (I). Clinical results. J Clin Periodontol. (1989) 16:647–53. 10.1111/j.1600-051X.1989.tb01034.x2693498PeikertSAFischerAKruseABAl-AhmadAWoelberJPVachKAdjuvant transgingival therapy with visible light plus water-filtered infrared-A (VIS + wIRA) in periodontal therapy-A randomized, controlled, stratified. Double-blinded clinical trial. Antibiotics (Basel). (2021) 10:180–7. 10.3390/antibiotics1003025133670214CobbCMSottosantiJS. A re-evaluation of scaling and root planing. J Periodontol. (2021) 92:1370–8. 10.1002/JPER.20-083933660307ClaffeyN. Decision making in periodontal therapy. The re-evaluation. J Clin Periodontol. (1991) 18:384–9. 10.1111/j.1600-051X.1991.tb02305.x1890217PreshawPMIdeMBissettSMHollidayRLansdowneNPickeringKNo benefit of an adjunctive phototherapy protocol in treatment of periodontitis: a split-mouth randomized controlled trial. J Clin Periodontol. (2021) 48:1093–102. 10.1111/jcpe.1346533817809SchmidtEKacirotiNLoescheW. Benefits of additional courses of systemic azithromycin in periodontal therapy. Gen Dent. (2011) 59:180–7; quiz 188–9. PMID: 21903541.21903541